Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
XPEL
XPEL
$1.22B
| $632K | ﹤0.01% |
+40,383
| New | +$552K |
|
2752
NACCO Industries
NC
$357M
| $629K | ﹤0.01% |
26,956
+1,720
| +7% | +$46.3K |
|
2753
Allient
ALNT
$1.49B
| $627K | ﹤0.01% |
26,628
+1,332
| +5% | +$27.8K |
|
|
ETNB
2754
DELISTED
89bio
ETNB
| $624K | ﹤0.01% |
31,286
+2,481
| +9% | +$60.3K |
|
2755
Anavex Life Sciences
AVXL
$255M
| $621K | ﹤0.01% |
126,184
+5,647
| +5% | +$21.3K |
|
2756
Atlassian
TEAM
$25.6B
| $620K | ﹤0.01% |
3,436
-6,808
| -66% | -$1.13M |
|
|
AKTS
2757
DELISTED
Akoustis Technologies Inc
AKTS
| $619K | ﹤0.01% |
74,591
+2,571
| +4% | +$19.9K |
|
2758
Loop Industries
LOOP
$35.3M
| $616K | ﹤0.01% |
68,346
+6,261
| +10% | +$53.8K |
|
|
LOVE
2759
DELISTED
LoveSac
LOVE
| $616K | ﹤0.01% |
23,464
+3,243
| +16% | +$49.3K |
|
|
RVLP
2760
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $615K | ﹤0.01% |
91,333
+26,181
| +40% | +$128K |
|
|
PZN
2761
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $610K | ﹤0.01% |
112,120
-1,395
| -1% | -$6.51K |
|
|
CCRD
2762
DELISTED
CoreCard
CCRD
| $604K | ﹤0.01% |
17,703
+1,137
| +7% | +$38.1K |
|
2763
Hingham Institution for Saving
HIFS
$627M
| $604K | ﹤0.01% |
3,594
+135
| +4% | +$21K |
|
2764
Bristow Group
VTOL
$1.34B
| $602K | ﹤0.01% |
43,176
-17,676
| -29% | -$189K |
|
2765
Hooker Furnishings Corp
HOFT
$150M
| $599K | ﹤0.01% |
30,772
+985
| +3% | +$15.8K |
|
2766
LifeVantage
LFVN
$81.1M
| $598K | ﹤0.01% |
44,207
+9,810
| +29% | +$136K |
|
2767
Blue Bird Corp
BLBD
$2.35B
| $594K | ﹤0.01% |
39,623
-85
| -0.2% | -$1.07K |
|
2768
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $594K | ﹤0.01% |
7,547
-28,724
| -79% | -$2.23M |
|
|
EIGR
2769
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $593K | ﹤0.01% |
2,057
+61
| +3% | +$18K |
|
|
ARA
2770
DELISTED
American Renal Associates Holdings, Inc
ARA
| $593K | ﹤0.01% |
90,830
-1,249
| -1% | -$8.06K |
|
|
ENZ
2771
DELISTED
Enzo Biochem, Inc.
ENZ
| $591K | ﹤0.01% |
263,822
+15,756
| +6% | +$40.5K |
|
2772
eGain
EGAN
$187M
| $589K | ﹤0.01% |
52,953
+2,318
| +5% | +$21.1K |
|
2773
Civista Bancshares
CIVB
$604M
| $583K | ﹤0.01% |
37,814
+1,706
| +5% | +$24.8K |
|
2774
Old Second Bancorp
OSBC
$1.29B
| $583K | ﹤0.01% |
74,828
+3,082
| +4% | +$22.8K |
|
|
SCU
2775
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $580K | ﹤0.01% |
44,790
+2,667
| +6% | +$34.2K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.